Market Overview

Cantor Fitzgerald Downgrades Cubist Pharmaceuticals, Inc. to Sell, Raises PT to $40.00.

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Latest Ratings for CBST

DateFirmActionFromTo
Dec 2014UBSDowngradesBuyNeutral
Dec 2014RBC CapitalDowngradesOutperformSector Perform
Dec 2014JefferiesDowngradesBuyHold

View More Analyst Ratings for CBST
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (CBST)